Living Donor Liver Transplantation in a Hepatitis B Patient with Acute on Chronic Liver Failure Accompanying Hepatocellular Carcinoma / 이화의대지
The Ewha Medical Journal
;
: 76-80, 2016.
Article
Dans Coréen
| WPRIM
| ID: wpr-89018
ABSTRACT
Acute clinical deterioration in patients with chronic liver disease is called acute on chronic liver failure (ACLF). Principles of management of ACLF consist of early identifying etiology of liver disease, rapid intervention of precipitating event and discreet intensive cares. Despite medical intensive cares, if liver failure progresses, liver transplantation could be the other option. Also, liver transplantation is the only treatment that offers a chance of cure for hepatocellular carcinoma (HCC) and the underlying liver cirrhosis simultaneously. Emergent living donor liver transplantation (LDLT) can be performed for patients with acute liver failure and improves survival rate, especially in circumstances which liver graft is often not available because of deceased donors are not affordable. Here, we describe a chronic hepatitis B patient who developed ACLF accompanying early HCC. Because he did not improved with medical care, he received emergent LDLT. After LDLT, he showed great improvement without critical complications.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Donneurs de tissus
/
Taux de survie
/
Transplantation hépatique
/
Défaillance hépatique aigüe
/
Défaillance hépatique
/
Carcinome hépatocellulaire
/
Donneur vivant
/
Hépatite B chronique
/
Transplants
/
Insuffisance hépatique aigüe sur chronique
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
The Ewha Medical Journal
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS